Clinical trials for Internal Medicine specialty
To evaluate the effect of plavix dosing in respect to how much time is needed to achieve maximum platelet inhibition which may decrease risk of thrombeombolic disease.
Diagnosis of protein losing nephropathy, cases with high indices of suspicion without definitive diagnosis will also be considered.
Dogs will be excluded if they have received steroids or any anticoagulant medications.
May be able to use a lower dose of plavix, therefore, more cost-effective.
Dr. Melissa Bucknoff, DVM
Phonoe: (508) 839-5395
To investigate and identify occult coagulation disorders in cats with cholestatic liver disease before any procedures (FNA, biopsy, surgery, e-tube placement).
serum bilirubin >/= 3, ALT/ALP > 2x upper limit of reference range.
PCV < 28%, obvious neoplasia, heart disease, icterus due to sepsis or hemolysis, meds (NSAIDs, steroids, fatty acids).
PT/PTT, plt count, pcv/ts, and TEG